Onyema Ogbuagu

机构：Yale University, Yale New Haven Health System · ORCID：0000-0001-7342-2608

发表论文 127 篇 · 总被引 3325 次 · h-index 21

代表论文

• Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons (2024 · New England Journal of Medicine · 被引 261)
• Resistance Analyses in Heavily Treatment-Experienced People With HIV Treated With the Novel HIV Capsid Inhibitor Lenacapavir After 2 Years (2025 · The Journal of Infectious Diseases · 被引 33)
• Efficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study (2025 · The Lancet Infectious Diseases · 被引 13)
• Lenacapavir treatment–emergent HIV-1 capsid resistance mutations are frequently associated with replication defects (2026 · Science Translational Medicine · 被引 12)
• Efficacy, safety, and pharmacokinetics of lenacapavir oral bridging when subcutaneous lenacapavir cannot be administered (2025 · AIDS · 被引 7)
• Efficacy and safety of lenacapavir, teropavimab, and zinlirvimab: week-26 primary outcome results from a multicentre, open-label, randomised, active-controlled, phase 2 study (2026 · The Lancet Microbe · 被引 5)